Weighted Average Number of Shares Outstanding, Diluted of FILANA THERAPEUTICS, INC. from 31 Mar 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
FILANA THERAPEUTICS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2011 to 31 Dec 2025.
  • FILANA THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 48,297,000, a 3.6% increase year-over-year.
  • FILANA THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 48,297,000, a 3.6% increase from 2024.
  • FILANA THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 46,604,000, a 11% increase from 2023.
  • FILANA THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 41,932,000, a 4.3% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

FILANA THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 48,297,000 +1,693,000 +3.6% 01 Oct 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 48,308,000 +332,000 +0.69% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 48,308,000 +2,106,000 +4.6% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 48,262,000 +4,160,000 +9.4% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 46,604,000 +4,672,000 +11% 01 Oct 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 47,976,000 +5,974,000 +14% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 46,202,000 +4,409,000 +11% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 44,102,000 +2,363,000 +5.7% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 41,932,000 01 Oct 2023 31 Dec 2023 10-K 12 Mar 2026 2025 FY
Q3 2023 42,002,000 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 41,793,000 +1,778,000 +4.4% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 41,739,000 +1,777,000 +4.4% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q2 2022 40,015,000 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 39,962,000 01 Jan 2022 31 Mar 2022 10-Q 01 May 2023 2023 Q1
Q1 2013 44,932,000 +176,000 +0.39% 01 Jan 2013 31 Mar 2013 10-Q 24 Apr 2013 2013 Q1
Q1 2012 44,756,000 +1,632,000 +3.8% 01 Jan 2012 31 Mar 2012 10-Q 24 Apr 2013 2013 Q1
Q1 2011 43,124,000 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1

FILANA THERAPEUTICS, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 48,297,000 +1,693,000 +3.6% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 46,604,000 +4,672,000 +11% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 41,932,000 +1,730,000 +4.3% 01 Jan 2023 31 Dec 2023 10-K 12 Mar 2026 2025 FY
2022 40,202,000 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2015 45,756,000 +487,000 +1.1% 01 Jan 2015 31 Dec 2015 10-K 03 Mar 2016 2015 FY
2014 45,269,000 +61,000 +0.14% 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2016 2015 FY
2013 45,208,000 +455,000 +1% 01 Jan 2013 31 Dec 2013 10-K 03 Mar 2016 2015 FY
2012 44,753,000 +593,000 +1.3% 01 Jan 2012 31 Dec 2012 10-K 18 Feb 2015 2014 FY
2011 44,160,000 01 Jan 2011 31 Dec 2011 10-K 05 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.